Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Pharmaterials

Pharmaterials
2000 FOUNDED
M&A STATUS
31-40 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Provider of medical contract development and manufacturing services. The company uses 13 GMP manufacturing suites to offer characterization and optimization of drug substance physical forms, development of preclinical and clinical formulations, clinical trial manufacturing and global drug product supply services in the United Kingdom.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Drug Delivery
Parent Company
Primary Office
  • Unit B, 5 Boulton Road
  • Reading RG2 0NH
  • England, United Kingdom

+44 0118 000 0000

Pharmaterials Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Pharmaterials‘s full profile, request access.

Request full access to PitchBook

Pharmaterials Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Avista Pharma Formerly PE-Backed Durham, NC 000 000000&0
0000000 Formerly PE-Backed Potters Bar, United Kingdom 00 000000000000
0000000 Corporation Dreieich, Germany 0000 000000000000
0000000 0000000 Failed Transaction (M&A) Mississauga, Canada 000 00000 000000&0
To view this company’s complete list of competitors, request access »

Pharmaterials Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Pharmaterials‘s full profile, request access.

Request full access to PitchBook

Pharmaterials Executive Team (3)

Name Title Board
Seat
Contact
Info
Syed Abidi Ph.D Chief Executive Officer
David Matkin Chief Scientific Officer

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »